Company Search:
Advanced Search
Sponsored Links
Achillion Pharmaceuticals, Inc. Company Snapshot
Achillion Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Achillion Pharmaceuticals with three other companies in this sector in the United States: Ligand Pharmaceuticals Inc (2015 sales of $71.91 million ), Newlink Genetics Corporation ($68.50 million of which 100% was Research And Development), and Eagle Pharmaceuticals, Inc ($66.23 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Achillion Pharmaceuticals, Inc.
  Stock Performance Chart for Achillion Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 4.27
(Figures in U.S. Dollars)
1 Week -0.2%   13 Weeks 5.2%  
4 Weeks -4.5%   52 Weeks -36.3%  
Achillion Pharmaceuticals, Inc. Key Data:
  Ticker: ACHN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 66,122,000
(Year Ending Jan 2016).
Employees: 48
  Currency: U.S. Dollars Market Cap: 583,627,392
  Fiscal Yr Ends: December Shares Outstanding: 136,680,888
  Share Type: Common Closely Held Shares: 18,503,304
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.